CLINICAL RESEARCH: BRACHIAL FLOW-MEDIATED DILATION AND ATHEROSCLEROSIS
Is the Association Between Flow-Mediated Dilation and Cardiovascular Risk Limited to Low-Risk Populations?
Daniel R. Witte, MD, PhD*,
Jan Westerink, MD ,
Eelco J. de Koning, MD, PhD, ,
Yolanda van der Graaf, MD, PhD*,
Diederick E. Grobbee, MD, PhD* and
Michiel L. Bots, MD, PhD*,*
* Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
Department of Internal Medicine, Section of Vascular Medicine, Diabetes and Endocrinology, University Medical Center Utrecht, Utrecht, the Netherlands
Department of Internal Medicine, Section of Nephrology, Leids University Medical Center, Leiden, the Netherlands
Manuscript received October 12, 2004;
revised manuscript received January 27, 2005,
accepted February 8, 2005.
* Reprint requests and correspondence: Dr. Michiel L. Bots, Julius Center for Health Sciences and Primary Care, Stratenum 6.131., University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. (Email: M.L.Bots{at}umcutrecht.nl).
OBJECTIVES: The aim of this research was to study whether the relation between endothelial function measured by flow-mediated dilation (FMD) of the brachial artery and cardiovascular risk factors is affected by the baseline cardiovascular risk.
BACKGROUND: Flow-mediated dilation of the brachial artery is widely used as a measure of endothelial function. Relations between FMD and most cardiovascular risk factors have been described.
METHODS: We performed a meta-regression analysis of 211 selected articles (399 populations) reporting on FMD and cardiovascular risk factors. Mean values of FMD; age; proportion of men; proportion of smokers; blood pressure; lipids; glucose; and the presence of diabetes mellitus, of hyperlipidemia, and of hypertension were retrieved from the articles. The 10-year risk of coronary heart disease (CHD) for each population was estimated based on the Framingham risk score. The relation between FMD and cardiovascular risk factors was assessed within each risk category by linear regression analysis, adjusting for age and gender, and weighted for the study size.
RESULTS: A relation between FMD and cardiovascular risk factors was most clear in the category with lowest baseline risk (below 2.8% per decade). In populations with low baseline risk, for each % increase in Framingham risk, FMD decreased by 1.42% (95% confidence interval: 0.65 to 2.19). In medium- and high-risk populations, FMD was not related to risk (–0.02% [–0.27 to 0.22] and 0.06% [–0.02 to 0.13], respectively). These findings were independent of differences in brachial lumen diameter and technical aspects of the FMD measurement.
CONCLUSIONS: Only in populations at low risk, endothelial function measured by FMD is related to the principal cardiovascular risk factors, and to the estimated 10-year risk of CHD.
|
Abbreviations and Acronyms
| | CHD = coronary heart disease | | FMD = flow-mediated dilation | | NO = nitric oxide |
|
Related Article
-
Primary and a Half Prevention: Can We Identify Asymptomatic Subjects With High Vascular Risk?
- David S. Celermajer
J. Am. Coll. Cardiol. 2005 45: 1994-1996.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
L. Hooper, P. A Kroon, E. B Rimm, J. S Cohn, I. Harvey, K. A Le Cornu, J. J Ryder, W. L Hall, and A. Cassidy
Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials
Am. J. Clinical Nutrition,
July 1, 2008;
88(1):
38 - 50.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Komai, Y. Higami, H. Tanaka, K. Honda, M. Juri, and Y. Okamura
Impaired Flow-Mediated Endothelium-Dependent and Endothelium-Independent Vasodilation of the Brachial Artery in Patients With Atherosclerotic Peripheral Vascular Disease
Angiology,
March 1, 2008;
59(1):
52 - 56.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K-K Lau, Y-H Chan, K-H Yiu, S Tam, S-W Li, C-P Lau, and H-F Tse
Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low-intermediate risk
Postgrad. Med. J.,
March 1, 2008;
84(989):
153 - 157.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Ghiadoni, G. Penno, C. Giannarelli, Y. Plantinga, M. Bernardini, L. Pucci, R. Miccoli, S. Taddei, A. Salvetti, and S. Del Prato
Metabolic Syndrome and Vascular Alterations in Normotensive Subjects at Risk of Diabetes Mellitus
Hypertension,
February 1, 2008;
51(2):
440 - 445.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. W. Rooke
Controversies in vascular screening art versus science
Vascular Medicine,
August 1, 2007;
12(3):
235 - 242.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. E. Deanfield, J. P. Halcox, and T. J. Rabelink
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Circulation,
March 13, 2007;
115(10):
1285 - 1295.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Parker, S. J. Ridout, and D. N. Proctor
Age and flow-mediated dilation: a comparison of dilatory responsiveness in the brachial and popliteal arteries
Am J Physiol Heart Circ Physiol,
December 1, 2006;
291(6):
H3043 - H3049.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Iida, H. Luo, K. Hagisawa, T. Akima, P. K. Shah, T. Z. Naqvi, and R. J. Siegel
Noninvasive Low-Frequency Ultrasound Energy Causes Vasodilation in Humans
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
532 - 537.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E Pyke and M. E Tschakovsky
The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function
J. Physiol.,
October 15, 2005;
568(2):
357 - 369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Celermajer
Primary and a Half Prevention: Can We Identify Asymptomatic Subjects With High Vascular Risk?
J. Am. Coll. Cardiol.,
June 21, 2005;
45(12):
1994 - 1996.
[Full Text]
[PDF]
|
|
|
|
